A model for the management of difficult to treat depression

A model for the management of difficult to treat depression

In this presentation a model for the management of difficult to treat depression (DTD) will be presented based upon a recently published international consensus statement (McAllister-Williams et al. 2020 Journal of Affective Disorders 267:264-282). This model emphasises the goals of: optimal symptom...

Full description

Bibliographic Details
Main Author:	H. Mcallister-Williams
Format:	Article
Language:	English
Published:	Cambridge University Press 2021-04-01
Series:	European Psychiatry
Subjects:	Treatment Resistant Depression Difficult to treat depression Depression
Online Access:	https://www.cambridge.org/core/product/identifier/S092493382100136X/type/journal_article

Similar Items

Viewpoint: Difficult-to-treat depression versus treatment-resistant depression: A new integrative perspective for managing depression
by: Walter Paganin
Published: (2023-01-01)

Is cognitive dysfunction involved in difficult-to-treat depression? Characterizing resistance from a cognitive perspective
by: Clara López-Solà, et al.
Published: (2020-01-01)

Schema therapy versus treatment as usual for outpatients with difficult-to-treat depression: study protocol for a parallel group randomized clinical trial (DEPRE-ST)
by: Ida-Marie T. P. Arendt, et al.
Published: (2024-04-01)

Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
by: Matteo Marcatili, et al.
Published: (2022-09-01)

Rethinking treatment-resistant depression to quasi-tenacious depression
by: Shokouh Arjmand, et al.
Published: (2023-01-01)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
by: Alina Wilkowska, et al.
Published: (2022-11-01)

Impact of Adjunctive VNS on Drug Load, Depression Severity, and Number of Neuromodulatory Maintenance Treatments
by: Erhan Kavakbasi, et al.
Published: (2024-02-01)

Treating with esketamine nasal, will increase blood pressure?
by: V. Rosello-Molina, et al.
Published: (2021-04-01)

Impact of invasive VNS on depression severity and the need of concomitant drug and neuromodulatory treatment dose
by: E. Kavakbasi, et al.
Published: (2022-06-01)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
by: Ennio Lubrano, et al.
Published: (2023-07-01)

Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine
by: Rodolphe H. Lebeau, et al.
Published: (2022-10-01)

Effectiveness of group cognitive behaviour therapy and contribution of positive automatic thoughts in treating depression
by: Low, Jia Liang
Published: (2016)

Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
by: Alin Codrut Nicolescu, et al.
Published: (2022-12-01)

Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis
by: Judit Majnik, et al.
Published: (2022-08-01)

Overcoming the myths of esketamine administration: different and not difficult
by: Florian Buchmayer, et al.
Published: (2023-11-01)

Difficult-to-control asthma management through the use of a specific protocol
by: Pedro Giavina-Bianchi, et al.
Published: (2010-01-01)

Clinical Outcomes, Microbiological Characteristics and Risk Factors for Difficult-to-Treat Resistance to Klebsiella pneumoniae Infection
by: Yang P, et al.
Published: (2022-10-01)

Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results
by: Elena A. Galushko, et al.
Published: (2022-06-01)

A retrospective examination of care pathways in individuals with treatment-resistant depression
by: Elana Day, et al.
Published: (2021-05-01)

#TreatmentResistantDepression: A qualitative content analysis of Tweets about difficult‐to‐treat depression
by: Amelia Talbot, et al.
Published: (2023-10-01)

Psilocybin's Emerging Role in Combating Depressive Disorder
by: Anna Jaremek, et al.
Published: (2023-08-01)

Effects of psilocybin-assisted therapy on treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression
by: Tor PC, et al.
Published: (2022-11-01)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01)

Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression
by: Aleksander Kwaśny, et al.
Published: (2024-02-01)

Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems
by: Ryu Watanabe, et al.
Published: (2022-10-01)

Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?
by: Paweł Pabjan, et al.
Published: (2022-01-01)

TREATMENT OF RESISTANT DEPRESSIONS AND CASE OF SUCCESSFUL USE OF DONEPEZIL HCl IN THEIR THERAPY
by: Dragan Terzič
Published: (2001-07-01)

Do baseline anxiety symptoms impact response to IV Ketamine in treatment resistant depression?
by: Zoe Schreiber, et al.
Published: (2021-12-01)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
by: Maria Gałuszko-Wȩgielnik, et al.
Published: (2023-07-01)

Healthcare costs and productivity losses in treatment-resistant depression in Finland
by: S. Rannanpää, et al.
Published: (2022-06-01)

Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
by: Courtney M. Vecera, et al.
Published: (2023-11-01)

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
by: Ju-Yang Jung, et al.
Published: (2023-09-01)

Real-world assessment of treatment inertia in the management of patients treated for major depressive disorder in the USA
by: John J Sheehan, et al.
Published: (2023-11-01)

Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
by: Cacciapuoti S, et al.
Published: (2023-09-01)

Combination therapy versus monotherapy for gastroesophageal reflux in children with difficult-to-treat bronchial asthma
by: Adel Salah Bediwy, et al.
Published: (2014-01-01)

Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation
by: Monika Elemery, et al.
Published: (2022-05-01)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
by: Maria Gałuszko-Węgielnik, et al.
Published: (2023-01-01)

Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients
by: Rao D, et al.
Published: (2019-12-01)

The Role of Vagus Nerve Stimulation in Depression: What We Know?
by: A. Fraga, et al.
Published: (2022-06-01)